Clinical and epidemiological characteristics of mpox among the insured population of La Libertad, 2022
DOI:
https://doi.org/10.24265/horizmed.2024.v24n1.06Keywords:
Monkeypox, Epidemics, HumansAbstract
Objective: To describe the clinical and epidemiological characteristics of monkeypox (mpox) among the insured population of La Libertad at Seguro Social de Salud (EsSalud - Social Health Insurance System). Materials and methods: A descriptive study, whose data were collected from clinical-epidemiological records and medical records; the cases with symptoms and positive PCR results were considered. The study variables were signs and symptoms, duration of the disease, medical history, sex, age, sexual orientation and place of contact with someone with mpox. Absolute and relative frequencies and confidence intervals were calculated. Results: Mpox was developed by the insured population between July 15 and December 31, 2022, and 48 cases were reported. The clinical characteristics were fever (54.17 %), asthenia and lymphadenopathy (52.08 %) (in the inguinal [25 %], cervical [12 %] and axillary [5 %] areas), myalgia and back pain (43.75 %), sore throat (37.50 %), chills (5 %) and polymorphous and centrifugal rash (100 %). In addition, there were complications (6.25 %) and one person died (case fatality rate 6.25 %). HIV immunosuppression, history of syphilis, genital herpes and genital warts occurred in 23 (47.92 %), four (8.33%), three (6.25 %) and two (4.17 %) cases, respectively. It affected 47 men (97.92 %), including 28 homosexuals (58.33 %), 13 heterosexuals (27.08 %) and seven bisexuals (14.58 %). Ten of them had contact with someone with mpox at home (20.83 %), seven at work (14.59 %), five at a party (10.42 %) and two at a bar (4.17 %). Conclusions: Mpox occurred mainly in homosexual and bisexual men not vaccinated against human smallpox. The most common symptoms were fever, asthenia and lymphadenopathy, mainly in the inguinal area. Moreover, all cases developed polymorphous rash, the duration of the disease was 17 to 45 days, complications were exceptional, 50 % of the cases had HIV immunosuppression and the case fatality rate was 6.25 %.
Downloads
References
WHO Media Team. WHO recommends new name for monkeypox disease [Internet]. Ginebra: World Health Organization; 2022. Disponible en: https://www.who.int/news/item/28-11-2022-whorecommends-new-name-for-monkeypox-disease
Rao A, Bachmann LH y Petersen B. What clinicians need to know about monkeypox in the United States and other countries [Internet]. United States: CDC; 2022. Disponible en: https://emergency.cdc. gov/coca/calls/2022/callinfo_052422.asp
International Commitee on Taxonomy and Viruses. Poxviridae [Internet]. Estados Unidos: ICTV; 2011. Disponible en: https://ictv. global/report_9th/dsDNA/poxviridae
Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis [Internet]. 2005;41(12):1742-951.
Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. Una historia de dos clados: virus de la viruela del simio. J Gen Virol [Internet]. 2005;86:2661-72.
Nolen L, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Introduction of monkeypox into a community and household: Risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg [Internet]. 2015;93(2):410-15.
World Health Organization. Mpox (monkeypox) [Internet]. Suiza: WHO; 2023. Disponible en: https://www.who.int/news-room/ questions-and-answers/item/monkeypox
European centre for disease prevention and control, WHO. Joint Epidemiological overview [Internet]. Estocolmo: ECDC; 2024. Disponible en: https://monkeypoxreport.ecdc.europa.eu/
Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill [Internet]. 2022;27(22):e0010141
Maksyutov R, Gavrilova E, Shchelkunov S. Species-specific differentiation of variola, monkeypox, and varicella-zoster viruses by multiplex real-time PCR assay. J Virol Methods [Internet]. 2016;236:215-20.
Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis [Internet]. 2004;4(1):15-25.
Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl Trop Dis [Internet]. 2021;16(2):e0010141.
Fang Yong SE, Ng OT, Ho ZJM, Mak TM, Marimuthu K, Vasoo S, et al. Imported Monkeypox, Singapore. Emerg Infect Dis [Internet]. 2020;26(8):1826-30.
European centre for disease prevention and control. ECDC releases f irst update to its rapid risk assessment on the monkeypox outbreak [Internet]. Estocolmo: ECDC; 2022. Disponible en: https://www. ecdc.europa.eu/en/news-events/ecdc-releases-first-update-itsrapid-risk-assessment-monkeypox-outbreak
Centro Nacional de Epidemiología, Prevención y Control de Enfermedades. Sala situacional de MPOX (viruela símica) [Internet]. Perú: MINSA; 2023. Disponible en: https://www.dge.gob.pe/salamonkeypox/
Centers for disease control and prevention. Risk of resurgent mpox outbreaks warrants increased prevention effort [Internet]. Estados Unidos: CDC; 2023. Disponible en: https://stacks.cdc.gov/view/ cdc/128710
Ministerio de Salud. Centro Nacional de Epidemiología, Prevención y Control de Enfermedades del Ministerio de Salud del Perú. Alerta Epidemiológica. Casos de viruela del mono en Lima y riesgo de propagación a otras regiones [Internet]. Perú: MINSA; 2022. Disponible en: https://www.dge.gob.pe/epipublic/uploads/alertas/ alertas_202216_01_191123.pdf
Asociación Médica Mundial. Declaración de Helsinki de la AMM – principios éticos para las investigaciones médicas en seres humanos [Internet]. Ferney-Voltaire: Asociación Médica Mundial; 2017. Disponible en: https://www.wma.net/es/policies-post/declaracionde-helsinki-de-la-amm-principios-eticos-para-las-investigacionesmedicas-en-seres-humanos/
Patel A, Bilinska J, Tam J, Da Silva D, Mason C, Daunt A, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ [Internet]. 2022;378:e072410.
Tarin-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Suner C, Anton A, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet [Internet]. 2022;400(10353):661-9.
Iñigo J, Gil E, Jiménez S, Martin F, Nieto A, Sánchez J, et al. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 april to 16 june 2022. Euro Surveill [Internet]. 2022;27(27):2200471.
Cataluña A, Clavo-Escribano P, Riera-Monroig J, Martín-Ezquerra G, Fernández-González P, Leonor Revelles-Peñas, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. BJD [Internet]. 2022;187(5):618-92.
Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E, et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Euro Surveill [Internet]. 2022;27(24):2200448
McCollum A, Damon I. Human monkeypox. Clin Infect Dis [Internet]. 2014;58(2):260-7.
Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka- Ogunleye A, Wakama P, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis [Internet]. 2020;71:e210–14.
Centros de Control y Prevención de Enfermedades. Multistate outbreak of monkeypox: Illinois, Indiana and Wisconsin, 2003. CDC [Internet]. 2003;290(1):30-1.
Rao AK, Petersen BW, Whitehill F, Razeq J, Isaacs S, Merchlinsky M, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices - United States. MMWR Morb Mortal Wkly Rep 2022 [Internet]. 2022;71:734–42.
Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses [Internet]. 2017;9(12):380.
Kunasekaran MP, Chen X, Costantino V, Chughtai AA, MacIntyre CR. Evidence for residual inmmunity to smallpox after vaccination and implications for re-emergence. AMSUS [Internet]. 2019;184(11-12):e668-e79.
UK Health Security Agency. Investigation into monkeypox outbreak in England: technical briefing [Internet]. Londres: UKHSA; 2022. Disponible en: https://www.gov.uk/government/publications/ monkeypox-outbreak-technical-briefings/investigationintomonkeypox-outbreak-in-england-technical-briefing-3#part-5clinical-experiencia
European Centre for Disease Prevention and Control (ECDC). ECDC publishes contact tracing guidance for the current monkeypox outbreak [Internet]. Estocolmo: ECDC; 2022. Disponible en: https://www.ecdc.europa.eu/en/news-events/ecdc-publishescontacttracing-guidance-current-monkeypox-outbreak
Chapman JL, Nichols DK, Martinez MJ, Raymond JW. Animal models of Orthopoxvirus infection. Vet Pathol [Internet]. 2010;47(5):852–70.
MacLeod DT, Nakatsuji T, Wang Z, di Nardo A, Gallo RL. Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes. J Invest Dermatol [Internet]. 2015;135(1):142–50
Centro Europeo para la Prevención y el Control de Enfermedades. Guía de prevención y control de la infección por viruela del mono para entornos de atención primaria y aguda [Internet]. Estocolmo: ECDC; 2022. Disponible en: https://www.ecdc.europa.eu/en/ publications-data/monkeypox-infection-prevention-and-controlguidance-primary-and-acute-care.
Organización Mundial de la Salud. Viruela símica [Internet]. Suiza: OMS; 2023. Disponible en: https://www.who.int/es/news-room/ fact-sheets/detail/monkeypox
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
